Zavation offers spinal implants, instruments, minimally invasive surgical solutions and interventional spine products
Zavation commercialised over 15 product families since inception. (Credit: Gerd Altmann from Pixabay)
LongueVue Capital (LVC) has divested its US-based spinal implant company Zavation Medical Products to an affiliate of Gemspring Capital Management for an undisclosed sum.
Based in Flowood of Mississippi, Zavation is engaged in the designing and manufacturing of spinal hardware and biologics
In 2017, LVC had collaborated with Zavation CEO Jeffrey Johnson and its management team for the acquisition of the spinal implant company.
LVC stated that it is the first institutional investor to Zavation that offered significant growth capital to professionalise the business and invest in new product development, infrastructure, operational enhancements, and human capital.
LVC co-founder and managing partner Rick Rees said: “Jeffrey and the Zavation team are a perfect example of how growth and value can be unlocked through LVC’s partnership approach of empowering entrepreneurs with infrastructure, expertise, and capital.”
Zavation offers spinal implants, instruments, minimally invasive surgical solutions and interventional spine products, in addition to biologics.
The company’s products are developed for use in various applications, including cervical, thoracolumbar, and interbody fusion.
Zavation, which has commercialised more than 15 product families since inception, also has a product development pipeline and multiple products are expected to be introduced next year.
The company operates a 12,500ft² facility in Tampa of Florida, in addition to the 35,000ft² facility in Flowood.
With a network of more than 300 distributors and around 100 employees, the company serves up to 400 hospitals and ambulatory surgical centres.
Zavation founder and CEO Jeffrey Johnson said: “LongueVue Capital has been a fantastic partner, and the LVC team was always a proactive resource as we explored new opportunities and worked through challenges.
“LVC’s experience growing healthcare, medical device, and manufacturing businesses—coupled with their commitment to providing the capital and resources we needed to reach our strategic goals—made them the ideal private equity partner for Zavation over the past four years.”